Supplier Research

Researchers Treat MRSA with Vitamin B3

September 11, 2012

A new study from the Journal of Clinical Investigation points to vitamin B3 as a potential way to treat serious staph infections, or MRSA. Physicians at Cedars-Sinai Medical Center, Los Angeles and the Linus Pauling Institute at Oregon State University collaborated to conduct a study in mice and human blood cells and found that high doses of B3, or niacin, was able to kill off Staphylococcus aureus(S. aureus) by 1,000 fold, particularly those resistant to antibiotics.
"This could give us a new way to treat staph infections that can be deadly, and might be used in combination with current antibiotics," said study author Adrian Gombart, an associate professor of microbiology at Oregon State University. "It's a way to tap into the power of the innate immune system and stimulate it to provide a more powerful and natural immune response."
For further information:

Related Health Conditions:

Related Market Segments:

blog comments powered by Disqus